Home/ Supplements/ Lysine/ L-Lysine 500 mg

L-Lysine 500 mg

product on market Tablet or Pill Indiana Botanic Gardens Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 33% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

L-lysine is an essential amino acid used to support protein synthesis and manage cold sore outbreaks, though evidence is limited. Calcium and phosphorus are minerals that contribute to bone health and structural integrity. Research supporting these ingredients is generally moderate to strong for basic nutritional maintenance.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for L-Lysine 500 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
Other Combinations
Product Type
33%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calcium
107 mg (11% DV)
83 mg (8% DV)
Within RDA (0.1× RDA) 13 studies (A:0, B:3)
500 mg
Market median: 500.0mg (159 products)

Other Ingredients

Stearic Acid Croscarmellose Sodium Magnesium Stearate Aqueous Film Coating
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Suggested Use: Take 1 tablet twice daily, as a dietary supplement, or as directed by a physician.

Warnings & Precautions

Warning: If you are taking any medications or are pregnant or nursing do not use prior to consulting a physician.

For your protection, this container has an outer safety seal. (Do not accept if missing or broken.)

Keep out of reach of children

Additional Information

Basic essential amino acid

Store in a dry, cool place.

Metadata

Product Details

UPC / SKU7 03308 82031 7
DSLD Entry Date2017-09-21
Product TypeOther Combinations
FormTablet or Pill
DSLD ID77946
Data Updated2026-04-11
Research

Research Evidence

3
Research Sources
74
Avg Quality
3
Meta Analysis
A Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2026 PubMed DOI
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
View all evidence for Lysine →
Compare

Similar Products

View all Lysine products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.